Immediate Impact
3 standout
Citing Papers
Vaccines and therapeutics for immunocompromised patients with COVID-19
2023 Standout
Therapeutic strategies for COVID-19: progress and lessons learned
2023 Standout
Works of Jonas Martzloff being referenced
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jonas Martzloff | 37 | 2 | 2 | 7 | 7 | 5 | 44 | |
| Phillip A. Kalra | 18 | 7 | 6 | 5 | 7 | 40 | ||
| Sabrina Ramelli | 23 | 1 | 2 | 10 | 7 | 48 | ||
| Susan Olaf Lindvig | 51 | 1 | 5 | 6 | 56 | |||
| M. Walters | 32 | 4 | 16 | 4 | 175 | |||
| Susan L. Dobson | 35 | 6 | 4 | 52 | ||||
| P. Henrivaux | 27 | 2 | 6 | 7 | 7 | 61 | ||
| Kevin Collins | 40 | 1 | 2 | 3 | 7 | 61 | ||
| Madison Ellis | 48 | 5 | 5 | 48 | ||||
| Mohamed Samir Abd El Ghafar | 55 | 1 | 5 | 5 | 67 | |||
| Shaghayegh Bayati | 27 | 7 | 5 | 41 |
All Works
Loading papers...